PRKCB and adrenal cortex carcinoma: We also observed that high PRKCB prolonged the survival time in ACC, BLCA, BRCA, CESC, HNSC, LGG, LIHC, LUAD, PRAD, SARC, and SKCM patients, but shortened the survival time in DLBC and PCPG.